newsfilter
← Latest News
GlobeNewswire·

Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data

SALT LAKE CITY, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, today announced a commercialization roadmap for its Precise